OrbiMed’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-183,750
| Closed | -$5.99M | – | 163 |
|
|
2021
Q4 | $5.99M | Hold |
183,750
| – | – | 0.08% | 130 |
|
|
2021
Q3 | $8.21M | Hold |
183,750
| – | – | 0.09% | 137 |
|
|
2021
Q2 | $10M | Hold |
183,750
| – | – | 0.1% | 123 |
|
|
2021
Q1 | $13.7M | Buy |
183,750
+27,500
| +18% | +$2.06M | 0.13% | 110 |
|
|
2020
Q4 | $17M | Buy |
+156,250
| New | +$17M | 0.15% | 106 |
|